InvestorsObserver is giving Timber Pharmaceuticals Inc (TMBR) an Analyst Rating Rank of 0, meaning TMBR is ranked higher by analysts than 0% of stocks. The average price target for TMBR is $ and analyst’s rate the stock as a Strong Sell
Why are Analyst Ratings Important?
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With Timber Pharmaceuticals Inc Stock Today?
Timber Pharmaceuticals Inc (TMBR) stock is trading at $2.09 as of 2:37 PM on Tuesday, Mar 2, a loss of -$0.18, or -7.93% from the previous closing price of $2.27. The stock has traded between $2.02 and $2.22 so far today. Volume today is less active than usual. So far 2,148,749 shares have traded compared to average volume of 9,154,460 shares.